Emergent BioSolutions was awarded a $628 million federal contract with no competitive bidding. Top executives received big bonuses while factories mostly sat idle and tens of millions of Covid-19 doses were thrown away.
read more
Source: NY Times
Sharon LaFraniere, Chris Hamby and Rebecca R. Ruiz